FILTER

LATEST INTERVIEWS

Sébastien de Montessus

CEO, ENDEAVOUR MINING CORPORATION
Endeavour Mining has continued all operations across its West African assets, amassing an impressive portfolio.

Martin Sack & Francisco Galvez

REGIONAL HEAD – AMERICAS & MANAGING DIRECTOR – MEXICO, LESCHACO
Leschaco in Mexico explains how the logistics sector has weathered the COVID storm.

Denis S. Frawley

PARTNER, ORMSTON LIST FRAWLEY LLP
Ormston List Frawley LLP comments on the current environment for M&A in the mining industry.

Dr. Tim Philippi

EXECUTIVE DIRECTOR, SINGAPOREAN-GERMAN CHAMBER OF INDUSTRY AND COMMERCE (SGC)
The Singaporean-German Chamber of Industry and Commerce speaks to GBR of how the two leading chemical hubs can cooperate.

Eduardo Cossio Chirinos

CEO, INCIMMET
INCIMMET explains why it is focusing on growth in the Colombian mining industry.

Abraham Klip Moshinsky

DIRECTOR GENERAL, UNIGEL MEXICO
Unigel has enjoyed a successful year in Mexico.

Hon. Greg Rickford

MINISTER OF ENERGY, MINES, NORTHERN DEVELOPMENT AND INDIGENOUS AFFAIRS, GOVERNMENT OF ONTARIO
Ontario’s Minister of Mines explains what his ministry did wrong during 2020 and also what they have set right to ensure mines lead Ontario’s recovery.

John McCluskey

PRESIDENT & CEO, ALAMOS GOLD
Alamos Gold explains how it protected its operations from COVID-19 and the progress at its Canadian and Mexican gold mines.

Serigne Ndanck Mbaye

CEO WEST AFRICA & COUNTRY HEAD GHANA, DHL
DHL West Africa explains how they were able to serve their customers in Africa throughout the pandemic.

Vinod Agnihotri

MANAGING DIRECTOR ASEAN, HEAD OF MPP – ASIA PACIFIC, LANXESS
Lanxess Asia Pacific explains how specialisation, digitalisation and environmental sustainability drive growth.

MACIG

SPANISH

SUBSCRIBE TO OUR NEWSLETTER

RECENT PUBLICATIONS

United States Life Sciences 2025 - Digital Interactive

Resilience amid uncertainty. These words encapsulate the US life sciences sector as it navigates 2025. While the industry has largely rebounded from the recent biotech bear market, with clinical trial starts and funding showing signs of rebound, headwinds remain.

PARTNER EVENTS